SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Formula Systems (1985) Ltd – ‘20-F’ for 12/31/18 – ‘R117’

On:  Wednesday, 5/15/19, at 8:05am ET   ·   For:  12/31/18   ·   Accession #:  1213900-19-8675   ·   File #:  0-29442

Previous ‘20-F’:  ‘20-F’ on 5/15/18 for 12/31/17   ·   Next:  ‘20-F’ on 6/29/20 for 12/31/19   ·   Latest:  ‘20-F/A’ on 12/11/23 for 12/31/22

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/15/19  Formula Systems (1985) Ltd        20-F       12/31/18  164:15M                                    Edgar Agents LLC/FA

Annual Report by a Foreign Non-Canadian Issuer   —   Form 20-F   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 20-F        Annual Report by a Foreign Non-Canadian Issuer      HTML   2.14M 
 2: EX-8.1      List of Subsidiaries                                HTML     41K 
 5: EX-13.1     Annual or Quarterly Report to Security Holders      HTML     41K 
 6: EX-13.2     Annual or Quarterly Report to Security Holders      HTML     42K 
 3: EX-12.1     Statement re: Computation of Ratios                 HTML     47K 
 4: EX-12.2     Statement re: Computation of Ratios                 HTML     47K 
 7: EX-15.1     Consent of Kost, Forer, Gabbay & Kasierer, A        HTML     40K 
                Member of Ernst & Young Global                                   
 8: EX-15.2     Consent of Kda Audit Corporation                    HTML     41K 
15: R1          Document and Entity Information                     HTML     72K 
16: R2          Consolidated Statements of Financial Position       HTML    161K 
17: R3          Consolidated Statements of Financial Position       HTML     55K 
                (Parenthetical)                                                  
18: R4          Consolidated Statements of Profit or Loss           HTML    104K 
19: R5          Consolidated Statements of Comprehensive Income     HTML     82K 
20: R6          Consolidated Statements of Changes in Equity        HTML    123K 
21: R7          Consolidated Statements of Other Comprehensive      HTML     54K 
                Income                                                           
22: R8          Consolidated Statements of Cash Flows               HTML    188K 
23: R9          Consolidated Statements of Cash Flows               HTML     61K 
                (Parenthetical)                                                  
24: R10         General                                             HTML     63K 
25: R11         Significant Accounting Policies                     HTML    349K 
26: R12         New Standards, Interpretations and Amendments       HTML     65K 
                Adopted By The Group                                             
27: R13         Business Combination, Significant Transaction and   HTML    166K 
                Sale of Business                                                 
28: R14         Marketable Securities                               HTML     66K 
29: R15         Prepaid Expenses and Other Accounts Receivable      HTML     47K 
30: R16         Fair Value Measurement                              HTML     68K 
31: R17         Investments in Companies Accounted for at Equity    HTML     82K 
                Method                                                           
32: R18         Property, Plants and Equipment, Net                 HTML     60K 
33: R19         Intangible Assets, Net                              HTML     53K 
34: R20         Goodwill                                            HTML     47K 
35: R21         Short Term Liabilities to Banks and Others          HTML     59K 
36: R22         Other Accounts Payable                              HTML     45K 
37: R23         Long Term Liabilities to Banks and Others           HTML     68K 
38: R24         Debentures                                          HTML    122K 
39: R25         Related Parties Transactions                        HTML     53K 
40: R26         Employee Option Plans                               HTML    126K 
41: R27         Employee Benefit Liabilities                        HTML     51K 
42: R28         Commitments and Contingencies                       HTML     95K 
43: R29         Equity                                              HTML     62K 
44: R30         Taxes on Income                                     HTML    118K 
45: R31         Supplementary Financial Statement Information       HTML     80K 
46: R32         Operating Segments                                  HTML    115K 
47: R33         Subsequent Events                                   HTML     50K 
48: R34         Significant Accounting Policies (Policies)          HTML    412K 
49: R35         General (Tables)                                    HTML     48K 
50: R36         Significant Accounting Policies (Tables)            HTML     85K 
51: R37         Business Combination, Significant Transaction and   HTML    169K 
                Sale of Business (Tables)                                        
52: R38         Marketable Securities (Tables)                      HTML     70K 
53: R39         Prepaid Expenses and Other Accounts Receivable      HTML     52K 
                (Tables)                                                         
54: R40         Fair Value Measurement (Tables)                     HTML     67K 
55: R41         Investments in Companies Accounted for at Equity    HTML     90K 
                Method (Tables)                                                  
56: R42         Property, Plants and Equipment, Net (Tables)        HTML     58K 
57: R43         Intangible Assets, Net (Tables)                     HTML     50K 
58: R44         Goodwill (Tables)                                   HTML     46K 
59: R45         Short Term Liabilities to Banks and Others          HTML     58K 
                (Tables)                                                         
60: R46         Other Accounts Payable (Tables)                     HTML     45K 
61: R47         Long Term Liabilities to Banks and Others (Tables)  HTML     64K 
62: R48         Debentures (Tables)                                 HTML    102K 
63: R49         Employee Option Plans (Tables)                      HTML    133K 
64: R50         Employee Benefit Liabilities (Tables)               HTML     46K 
65: R51         Commitments and Contingencies (Tables)              HTML     50K 
66: R52         Equity (Tables)                                     HTML     52K 
67: R53         Taxes on Income (Tables)                            HTML     94K 
68: R54         Supplementary Financial Statement Information       HTML     94K 
                (Tables)                                                         
69: R55         Operating Segments (Tables)                         HTML     95K 
70: R56         General (Details)                                   HTML     56K 
71: R57         General (Details Textual)                           HTML     44K 
72: R58         Significant Accounting Policies (Details)           HTML     57K 
73: R59         Significant Accounting Policies (Details 1)         HTML     54K 
74: R60         Significant Accounting Policies (Details 2)         HTML     83K 
75: R61         Significant Accounting Policies (Details 3)         HTML     68K 
76: R62         Significant Accounting Policies (Details 4)         HTML     50K 
77: R63         Significant Accounting Policies (Details Textual)   HTML     72K 
78: R64         New Standards, Interpretations and Amendments       HTML     46K 
                Adopted By The Group (Details)                                   
79: R65         Business Combination, Significant Transaction and   HTML     59K 
                Sale of Business (Details)                                       
80: R66         Business Combination, Significant Transaction and   HTML     55K 
                Sale of Business (Details 1)                                     
81: R67         Business Combination, Significant Transaction and   HTML     53K 
                Sale of Business (Details 2)                                     
82: R68         Business Combination, Significant Transaction and   HTML     55K 
                Sale of Business (Details 3)                                     
83: R69         Business Combination, Significant Transaction and   HTML     74K 
                Sale of Business (Details 4)                                     
84: R70         Business Combination, Significant Transaction and   HTML     51K 
                Sale of Business (Details 5)                                     
85: R71         Business Combination, Significant Transaction and   HTML     55K 
                Sale of Business (Details 6)                                     
86: R72         Business Combination, Significant Transaction and   HTML     55K 
                Sale of Business (Details 7)                                     
87: R73         Business Combination, Significant Transaction and   HTML     55K 
                Sale of Business (Details 8)                                     
88: R74         Business Combination, Significant Transaction and   HTML     56K 
                Sale of Business (Details 9)                                     
89: R75         Business Combination, Significant Transaction and   HTML     57K 
                Sale of Business (Details 10)                                    
90: R76         Business Combination, Significant Transaction and   HTML     55K 
                Sale of Business (Details 11)                                    
91: R77         Business Combination, Significant Transaction and   HTML     58K 
                Sale of Business (Details 12)                                    
92: R78         Business Combination, Significant Transaction and   HTML     55K 
                Sale of Business (Details 13)                                    
93: R79         Business Combination, Significant Transaction and   HTML     57K 
                Sale of Business (Details 14)                                    
94: R80         Business Combination, Significant Transaction and   HTML     55K 
                Sale of Business (Details 15)                                    
95: R81         Business Combination, Significant Transaction and   HTML     58K 
                Sale of Business (Details 16)                                    
96: R82         Business Combination, Significant Transaction and   HTML     55K 
                Sale of Business (Details 17)                                    
97: R83         Business Combination, Significant Transaction and   HTML     54K 
                Sale of Business (Details 18)                                    
98: R84         Business Combination, Significant Transaction and   HTML     58K 
                Sale of Business (Details 19)                                    
99: R85         Business Combination, Significant Transaction and   HTML     57K 
                Sale of Business (Details 20)                                    
100: R86         Business Combination, Significant Transaction and   HTML     56K  
                Sale of Business (Details 21)                                    
101: R87         Business Combination, Significant Transaction and   HTML     57K  
                Sale of Business (Details 22)                                    
102: R88         Business Combination, Significant Transaction and   HTML     60K  
                Sale of Business (Details Textual)                               
103: R89         Business Combination, Significant Transaction and   HTML     56K  
                Sale of Business (Details Textual 1)                             
104: R90         Business Combination, Significant Transaction and   HTML    152K  
                Sale of Business (Details Textual 2)                             
105: R91         Business Combination, Significant Transaction and   HTML    208K  
                Sale of Business (Details Textual 3)                             
106: R92         Marketable Securities (Details)                     HTML     50K  
107: R93         Marketable Securities (Details 1)                   HTML     51K  
108: R94         Marketable Securities (Details 2)                   HTML     66K  
109: R95         Marketable Securities (Details 3)                   HTML     49K  
110: R96         Marketable Securities (Details Textual)             HTML     47K  
111: R97         Disclosure - Prepaid Expenses and Other Accounts    HTML     55K  
                Receivable (Details)                                             
112: R98         Fair Value Measurement (Details)                    HTML     83K  
113: R99         Investments in Companies Accounted for at Equity    HTML     49K  
                Method (Details)                                                 
114: R100        Investments in Companies Accounted for at Equity    HTML     50K  
                Method (Details 1)                                               
115: R101        Investments in Companies Accounted for at Equity    HTML     52K  
                Method (Details 2)                                               
116: R102        Investments in Companies Accounted for at Equity    HTML     78K  
                Method (Details 3)                                               
117: R103        Investments in Companies Accounted for at Equity    HTML     83K  
                Method (Details 4)                                               
118: R104        Investments in Companies Accounted for at Equity    HTML     47K  
                Method (Details Textual)                                         
119: R105        Property, Plants and Equipment, Net (Details)       HTML     59K  
120: R106        Property, Plants and Equipment, Net (Details        HTML     43K  
                Textual)                                                         
121: R107        Intangible Assets, Net (Details)                    HTML     62K  
122: R108        Intangible Assets, Net (Details Textual)            HTML     43K  
123: R109        Goodwill (Details)                                  HTML     50K  
124: R110        Short Term Liabilities to Banks and Others          HTML     64K  
                (Details)                                                        
125: R111        Other Accounts Payable (Details)                    HTML     50K  
126: R112        Long Term Liabilities to Banks and Others           HTML     62K  
                (Details)                                                        
127: R113        Long Term Liabilities to Banks and Others (Details  HTML     51K  
                1)                                                               
128: R114        Long Term Liabilities to Banks and Others (Details  HTML     50K  
                Textual)                                                         
129: R115        Debentures (Details)                                HTML     77K  
130: R116        Debentures (Details 1)                              HTML     52K  
131: R117        Debentures (Details Textual)                        HTML    110K  
132: R118        Related Parties Transactions (Details)              HTML     63K  
133: R119        Employee Option Plans (Details)                     HTML     53K  
134: R120        Employee Option Plans (Details 1)                   HTML     76K  
135: R121        Employee Option Plans (Details 2)                   HTML     74K  
136: R122        Employee Option Plans (Details 3)                   HTML     93K  
137: R123        Employee Option Plans (Details 4)                   HTML     74K  
138: R124        Employee Option Plans (Details 5)                   HTML     74K  
139: R125        Employee Option Plans (Details Textual)             HTML    173K  
140: R126        Employee Benefit Liabilities (Details)              HTML     47K  
141: R127        Commitments and Contingencies (Details)             HTML     57K  
142: R128        Commitments and Contingencies (Details 1)           HTML     53K  
143: R129        Commitments and Contingencies (Details Textual)     HTML    160K  
144: R130        Equity (Details)                                    HTML     51K  
145: R131        Equity (Details Textual)                            HTML     57K  
146: R132        Taxes on Income (Details)                           HTML     48K  
147: R133        Taxes on Income (Details 1)                         HTML     50K  
148: R134        Taxes on Income (Details 2)                         HTML     49K  
149: R135        Taxes on Income (Details 3)                         HTML     50K  
150: R136        Taxes on Income (Details 4)                         HTML     72K  
151: R137        Taxes on Income (Details 5)                         HTML     49K  
152: R138        Taxes on Income (Details Textual)                   HTML     98K  
153: R139        Supplementary Financial Statement Information       HTML     52K  
                (Details)                                                        
154: R140        Supplementary Financial Statement Information       HTML     60K  
                (Details 1)                                                      
155: R141        Supplementary Financial Statement Information       HTML     54K  
                (Details 2)                                                      
156: R142        Supplementary Financial Statement Information       HTML     61K  
                (Details 3)                                                      
157: R143        Supplementary Financial Statement Information       HTML     57K  
                (Details 4)                                                      
158: R144        Operating Segments (Details)                        HTML     53K  
159: R145        Operating Segments (Details 1)                      HTML     97K  
160: R146        Operating Segments (Details Textual)                HTML     61K  
161: R147        Subsequent Events (Details)                         HTML     61K  
163: XML         IDEA XML File -- Filing Summary                      XML    323K  
162: EXCEL       IDEA Workbook of Financial Reports                  XLSX    221K  
 9: EX-101.INS  XBRL Instance -- forty-20181231                      XML   4.44M 
11: EX-101.CAL  XBRL Calculations -- forty-20181231_cal              XML    339K 
12: EX-101.DEF  XBRL Definitions -- forty-20181231_def               XML   1.48M 
13: EX-101.LAB  XBRL Labels -- forty-20181231_lab                    XML   2.35M 
14: EX-101.PRE  XBRL Presentations -- forty-20181231_pre             XML   1.97M 
10: EX-101.SCH  XBRL Schema -- forty-20181231                        XSD    592K 
164: ZIP         XBRL Zipped Folder -- 0001213900-19-008675-xbrl      Zip    396K  


‘R117’   —   Debentures (Details Textual)


This is an IDEA Financial Report.  [ Alternative Formats ]



 
v3.19.1
Debentures (Details Textual)
₪ in Thousands, $ in Thousands
1 Months Ended 12 Months Ended
USD ($)
ILS (₪)
USD ($)
USD ($)
ILS (₪)
Debentures (Textual)                  
Interest expenses     $ 5,165   $ 2,441        
Amortization of debt premium, discount and issuance costs, net     289   391        
Public offering, description Formula concluded a public offering in Israel on the Tel-Aviv Stock Exchange (the "TASE") of (i) NIS102.3 million par value of Series A Secured Debentures (the "Formula's Series A Secured Debentures") and of (ii) NIS125 million par value of Series B Convertible Debentures that are linked to the US Dollar based on the exchange rate on September 8, 2015 of 3.922 (the "Formula's Series B Convertible Debentures"). Formula's Debentures were offered and sold pursuant to a shelf prospectus filed with the Israeli Securities Authority (the "ISA") and TASE on August 6, 2015, amended thereafter on September 3, 2015 and which term was extended in July 2017 until August 6, 2018.                
Convertible debentures         78,229        
Interest rate               1.85% 2.60%
Debentures amount     $ 45,356   $ 78,229      
Sapiens' Series B Debentures [Member]                  
Debentures (Textual)                  
Description of debentures   Sapiens issued its unsecured Series B Debentures in the aggregate principal amount of NIS 280,000 (approximately $79,186), linked to US dollars, payable in eight equal annual payments of $9,898 on January 1 of each of the years 2019 through 2026. The outstanding principal amount of Sapiens' Series B Debentures will bear a fixed interest rate of 3.37% per annum, payable on January 1 and July 1 of each of the years 2018 through 2025, with one final interest payment on January 1, 2026. Debt discount and issuance costs were approximately $956, allocated to Sapiens' Series B Debentures discount and are amortized as financial expenses over the term of the Series B Debentures due in 2026. The first installment, in the amount of $9,898, was paid in January 1, 2019.              
Series A Secured Debentures [Member]                  
Debentures (Textual)                  
Issued purchase price, percentage     100.00%       100.00%    
Commission     $ 129            
Issuance costs     $ 190            
Description of debentures     On January 31, 2018, the Company consummated a private placement to qualified investors in Israel, of an additional, aggregate NIS 150 million par value of Series A Secured Debentures at a price of NIS 1,034.7 for each NIS 1,000 principal amount. The aggregate gross proceeds totaled NIS 155,205 (approximately $45,581), excluding issuance costs of $225. As a result of the private placement, the total outstanding principal amount of the Series A Secured Debentures increased to approximately NIS 239,478 million (approximately $70,331). The terms of the Series A Secured Debentures sold in the private placement are identical in all respects to those of the Series A Secured Debentures sold in Formula’s September 2015 public offering. On January 31, 2018, the Company consummated a private placement to qualified investors in Israel, of an additional, aggregate NIS 150 million par value of Series A Secured Debentures at a price of NIS 1,034.7 for each NIS 1,000 principal amount. The aggregate gross proceeds totaled NIS 155,205 (approximately $45,581), excluding issuance costs of $225. As a result of the private placement, the total outstanding principal amount of the Series A Secured Debentures increased to approximately NIS 239,478 million (approximately $70,331). The terms of the Series A Secured Debentures sold in the private placement are identical in all respects to those of the Series A Secured Debentures sold in Formula’s September 2015 public offering.          
Series A Secured Debentures [Member] | Fixed annual interest rate [Member]                  
Debentures (Textual)                  
Interest rate     2.80%       2.80%    
Series A Secured Debentures [Member] | NIS [Member]                  
Debentures (Textual)                  
Debentures amount | ₪       ₪ 102,260          
Series B Convertible Debentures [Member]                  
Debentures (Textual)                  
Conversion component valued     $ 1,248            
Convertible debentures     $ 32,364            
Issued purchase price, percentage     102.00%       102.00%    
Commission     $ 131            
Issuance costs     236            
Debt discount and issuance costs     367            
Bonds amounted     $ 32,785            
Principal amount of convertible bonds, percentage     10.00% 10.00%          
Exchange rate, description     The principal of the Bonds is subject to adjustment based on changes in the exchange rate between the NIS and the U.S. Dollar relative to the exchange rate on September 8, 2015 (3.922), and will be repaid on March 26, 2019. The principal of the Bonds is subject to adjustment based on changes in the exchange rate between the NIS and the U.S. Dollar relative to the exchange rate on September 8, 2015 (3.922), and will be repaid on March 26, 2019.          
Conversion price, description     Formula's ordinary shares, from the date of issuance and until March 10, 2019, at conversion price of, as of the date of the issuance, NIS 157 par value of Convertible Debentures per one share, adjusted for events that the Company effects a share split or reverse share split, a rights offering or a distribution of bonus shares or a cash dividend. As of December 31, 2017 and 2018, the adjusted conversion price to one share was NIS 150.27542 par value and 147.54176 par value, respectively, following cash dividend distributions. Formula's ordinary shares, from the date of issuance and until March 10, 2019, at conversion price of, as of the date of the issuance, NIS 157 par value of Convertible Debentures per one share, adjusted for events that the Company effects a share split or reverse share split, a rights offering or a distribution of bonus shares or a cash dividend. As of December 31, 2017 and 2018, the adjusted conversion price to one share was NIS 150.27542 par value and 147.54176 par value, respectively, following cash dividend distributions.          
Result of conversions effected, description     As a result of conversions that were effected during 2018 and mainly 2019, prior to the maturity of the Series B Convertible Debentures in March 2019, holders of Series B Convertible Debentures converted an aggregate principal par value amount of NIS 80,484 (of which NIS 231.7 were converted in 2018) into 545,485 ordinary shares (of which 1,556 ordinary shares were issued in 2018), constituting 3.57% of Formula's issued and outstanding share capital (following those conversions). The remaining outstanding Series B Convertible Debentures matured on March 26, 2019, and the remaining outstanding principal of NIS 44,516 (or $11,350) and interest on those debentures of $1,135 were paid on that date. As a result of conversions that were effected during 2018 and mainly 2019, prior to the maturity of the Series B Convertible Debentures in March 2019, holders of Series B Convertible Debentures converted an aggregate principal par value amount of NIS 80,484 (of which NIS 231.7 were converted in 2018) into 545,485 ordinary shares (of which 1,556 ordinary shares were issued in 2018), constituting 3.57% of Formula's issued and outstanding share capital (following those conversions). The remaining outstanding Series B Convertible Debentures matured on March 26, 2019, and the remaining outstanding principal of NIS 44,516 (or $11,350) and interest on those debentures of $1,135 were paid on that date.          
Series B Convertible Debentures [Member] | Fixed annual interest rate [Member]                  
Debentures (Textual)                  
Interest rate     2.74%       2.74%    
Series B Convertible Debentures [Member] | NIS [Member]                  
Debentures (Textual)                  
Bonds amounted | ₪             ₪ 127,500    
Series C Secured Debentures [Member]                  
Debentures (Textual)                  
Description of debentures     On March 31, 2019, Formula consummated a public offering in Israel of a new series of secured debentures - Series C Secured Debentures' in an aggregate NIS 300,000 par value amount, at a price of NIS 1,000 for each unit of NIS 1,000 principal amount. The aggregate gross proceeds from the public offering totaled NIS 298,500 (approximately $82,186). For further information, see Note 24 (a). On March 31, 2019, Formula consummated a public offering in Israel of a new series of secured debentures - Series C Secured Debentures' in an aggregate NIS 300,000 par value amount, at a price of NIS 1,000 for each unit of NIS 1,000 principal amount. The aggregate gross proceeds from the public offering totaled NIS 298,500 (approximately $82,186). For further information, see Note 24 (a).          

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘20-F’ Filing    Date    Other Filings
1/1/26
Filed on:5/15/19
3/31/19
3/26/196-K
3/10/19
1/1/19
For Period end:12/31/18
8/6/18
1/31/18SC 13G/A
12/31/1720-F
9/30/17
2/28/17
12/31/1620-F,  20-F/A
11/30/16
9/16/156-K
9/8/15
9/3/15
8/6/15
 List all Filings 
Top
Filing Submission 0001213900-19-008675   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 15, 12:38:51.1pm ET